A recent study demonstrated that miR-122 mitigates sepsis-induced liver injury by targeting the BCL2A1 signaling pathway, thereby reducing macrophage apoptosis and alleviating inflammatory responses (Liu et al., 2024). This evidence concerns the gene BCL2A1 and Sepsis.